The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACADIA PHARMACEUTICALS INC | COM | 004225108 | 3,842 | 137,773 | SH | SOLE | 137,773 | 0 | 0 | ||
ACCELERON PHARMA INC | COM | 00434H108 | 5,397 | 177,643 | SH | SOLE | 177,643 | 0 | 0 | ||
ACHAOGEN INC | COM | 004449104 | 3,358 | 154,538 | SH | SOLE | 154,538 | 0 | 0 | ||
ADAMAS PHARMACEUTICALS INC | COM | 00548A106 | 3,236 | 185,234 | SH | SOLE | 185,234 | 0 | 0 | ||
AERIE PHARMACEUTICALS INC | COM | 00771V108 | 4,926 | 93,822 | SH | SOLE | 93,822 | 0 | 0 | ||
AGIOS PHARMACEUTICALS INC | COM | 00847X104 | 1,904 | 37,000 | SH | SOLE | 37,000 | 0 | 0 | ||
ALEXION PHARMACEUTICALS INC | COM | 015351109 | 11,758 | 96,641 | SH | SOLE | 96,641 | 0 | 0 | ||
AMGEN INC | COM | 031162100 | 8,629 | 50,104 | SH | SOLE | 50,104 | 0 | 0 | ||
ARRAY BIOPHARMA INC | COM | 04269X105 | 2,681 | 320,744 | SH | SOLE | 320,744 | 0 | 0 | ||
BIOGEN INC | COM | 09062X103 | 16,577 | 61,108 | SH | SOLE | 61,108 | 0 | 0 | ||
BIOMARIN PHARMACEUTICALS INC | COM | 09061G101 | 10,732 | 118,166 | SH | SOLE | 118,166 | 0 | 0 | ||
CALITHERA BIOSCIENCES INC | COM | 13089P101 | 3,623 | 244,000 | SH | SOLE | 244,000 | 0 | 0 | ||
CELGENE CORP | COM | 151020104 | 23,053 | 177,522 | SH | SOLE | 177,522 | 0 | 0 | ||
CLOVIS ONCOLOGY INC | COM | 189464100 | 3,276 | 35,000 | SH | SOLE | 35,000 | 0 | 0 | ||
DERMIRA INC | COM | 24983L104 | 3,756 | 129,000 | SH | SOLE | 129,000 | 0 | 0 | ||
ENTELLUS MED INC | COM | 29363K105 | 5,655 | 341,468 | SH | SOLE | 341,468 | 0 | 0 | ||
EXELIXIS INC | COM | 30161Q104 | 5,096 | 207,000 | SH | SOLE | 207,000 | 0 | 0 | ||
FIVE PRIME THERAPEUTICS INC | COM | 33830X104 | 1,235 | 41,000 | SH | SOLE | 41,000 | 0 | 0 | ||
FOAMIX PHARMACEUTICALS LTD | SHS | M46135105 | 1,666 | 358,975 | SH | SOLE | 358,975 | 0 | 0 | ||
GILEAD SCIENCES INC | COM | 375558103 | 8,619 | 121,784 | SH | SOLE | 121,784 | 0 | 0 | ||
GLOBAL BLOOD THERAPEUTICS INC | COM | 37890U108 | 561 | 20,500 | SH | SOLE | 20,500 | 0 | 0 | ||
GW PHARMACEUTICALS PLC | ADS | 36197T103 | 922 | 9,200 | SH | SOLE | 9,200 | 0 | 0 | ||
HALOZYME THERAPEUTICS INC | COM | 40637H109 | 2,621 | 204,633 | SH | SOLE | 204,633 | 0 | 0 | ||
HORIZON PHARMA PLC | SHS | G4617B105 | 2,004 | 169,000 | SH | SOLE | 169,000 | 0 | 0 | ||
ILLUMINA INC | COM | 452327109 | 2,367 | 13,641 | SH | SOLE | 13,641 | 0 | 0 | ||
INCYTE CORP | COM | 45337C102 | 9,755 | 77,475 | SH | SOLE | 77,475 | 0 | 0 | ||
INTERCEPT PHARMACEUTICALS IN | COM | 45845P108 | 1,351 | 11,155 | SH | SOLE | 11,155 | 0 | 0 | ||
IONIS PHARMACEUTICALS INC | COM | 462222100 | 2,620 | 51,500 | SH | SOLE | 51,500 | 0 | 0 | ||
IRONWOOD PHARMACEUTICALS INC | COM CL A | 46333X108 | 1,113 | 59,000 | SH | SOLE | 59,000 | 0 | 0 | ||
JAZZ PHARMACEUTICALS PLC | SHS USD | G50871105 | 4,199 | 27,000 | SH | SOLE | 27,000 | 0 | 0 | ||
KALVISTA PHARMACEUTICALS INC | COM | 483497103 | 2,276 | 322,436 | SH | SOLE | 322,436 | 0 | 0 | ||
KITE PHARMA INC | COM | 49803L109 | 2,291 | 22,100 | SH | SOLE | 22,100 | 0 | 0 | ||
LIGAND PHARMACEUTICALS INC | COM | 53220K504 | 1,093 | 9,000 | SH | SOLE | 9,000 | 0 | 0 | ||
MACROGENICS INC | COM | 556099109 | 945 | 54,000 | SH | SOLE | 54,000 | 0 | 0 | ||
MERUS NV | COM | N5749R100 | 966 | 60,946 | SH | SOLE | 60,946 | 0 | 0 | ||
MYLAN NV | SHS EURO | N59465109 | 5,433 | 140,000 | SH | SOLE | 140,000 | 0 | 0 | ||
NEURODERM LTD | ORD SHS | M74231107 | 5,007 | 168,025 | SH | SOLE | 168,025 | 0 | 0 | ||
OMEROS CORP | COM | 682143102 | 602 | 30,239 | SH | SOLE | 30,239 | 0 | 0 | ||
PACIRA PHARMACEUTICALS INC | COM | 695127100 | 762 | 16,000 | SH | SOLE | 16,000 | 0 | 0 | ||
PARATEK PHARMACEUTICALS INC | COM | 699374302 | 1,395 | 58,000 | SH | SOLE | 58,000 | 0 | 0 | ||
PIERIS PHARMACEUTICALS INC | COM | 720795103 | 712 | 141,061 | SH | SOLE | 141,061 | 0 | 0 | ||
PORTOLA PHARMACEUTICALS INC | COM | 737010108 | 4,269 | 76,000 | SH | SOLE | 76,000 | 0 | 0 | ||
PROTHENA CORP PLC | SHS | G72800108 | 2,274 | 42,000 | SH | SOLE | 42,000 | 0 | 0 | ||
RADIUS HEALTH INC | COM | 750469207 | 5,194 | 114,799 | SH | SOLE | 114,799 | 0 | 0 | ||
REGENERON PHARMACEUTICALS | COM | 75886F107 | 23,639 | 48,130 | SH | SOLE | 48,130 | 0 | 0 | ||
SAGE THERAPEUTICS INC | COM | 78667J108 | 1,353 | 16,996 | SH | SOLE | 16,996 | 0 | 0 | ||
SAREPTA THERAPEUTICS INC | COM | 803607100 | 2,056 | 61,000 | SH | SOLE | 61,000 | 0 | 0 | ||
SEATTLE GENETICS INC | COM | 812578102 | 3,363 | 65,000 | SH | SOLE | 65,000 | 0 | 0 | ||
SHIRE PLC | SPONSORED ADR | 82481R106 | 5,404 | 32,700 | SH | SOLE | 32,700 | 0 | 0 | ||
STEMLINE THERAPEUTICS INC | COM | 85858C107 | 4,168 | 453,000 | SH | SOLE | 453,000 | 0 | 0 | ||
SUPERNUS PHARMACEUTICALS INC | COM | 868459108 | 902 | 20,953 | SH | SOLE | 20,953 | 0 | 0 | ||
SYNERGY PHARMACEUTICALS DEL | COM | 871639308 | 3,428 | 772,000 | SH | SOLE | 772,000 | 0 | 0 | ||
TESARO INC | COM | 881569107 | 4,685 | 33,500 | SH | SOLE | 33,500 | 0 | 0 | ||
TRANSENTERIX INC | COM | 89366M201 | 625 | 889,082 | SH | SOLE | 889,082 | 0 | 0 | ||
TRILLIUM THERAPEUTICS INC | COM | 89620X506 | 693 | 161,069 | SH | SOLE | 161,069 | 0 | 0 | ||
UNITED THERAPEUTICS CORP DEL | COM | 91307C109 | 2,815 | 21,700 | SH | SOLE | 21,700 | 0 | 0 | ||
VANDA PHARMACEUTICALS INC | COM | 921659108 | 1,022 | 62,905 | SH | SOLE | 62,905 | 0 | 0 | ||
VERACYTE INC | COM | 92337F107 | 1,414 | 170,000 | SH | SOLE | 170,000 | 0 | 0 | ||
VERTEX PHARMACEUTICALS INC | COM | 92532F100 | 17,465 | 135,522 | SH | SOLE | 135,522 | 0 | 0 | ||
XENCOR INC | COM | 98401F105 | 380 | 18,000 | SH | SOLE | 18,000 | 0 | 0 |